altius.com

New rules recently came into force, modernising how frontier workers enter and leave Belgium. Frontier workers who do not have the nationality of an EEA country or Switzerland must now hold an Annex 64, or a specific D visa, to enter and leave Belgium for a period exceeding 90 days. This article gives a short overview of the main changes. Importantly, these changes do not affect a frontier worker’s right to work in Belgium.

CJEU’s judgment of 8 September 2026 in Case C-298/23, Inter IKEA Systems BV v Algemeen Vlaams Belang VZW (Reference for a preliminary ruling from the Nederlandstalige Ondernemingsrechtbank Brussel – Brussels Dutch-speaking Business Court, Belgium) On 14 November 2022, the Belgian far-right political party Vlaams Belang publicly presented, at a press conference, its programme for reforming asylum and immigration policy under the name “IKEA-PLAN – Immigratie Kan Echt Anders” (“IKEA plan –...

ALTIUS is delighted to announce the promotion of Jan Clinck to partner. Jan has been a pillar of ALTIUS’ ICT department for many years, and has contributed to ALTIUS’ growth and development through his hard work, commitment, and innovative thinking. Let’s ‘fire up’ Jan with some questions and introduce you to our brand new partner. I joined ALTIUS 9 years ago, in July 2017. Before that, I spent five years as a lawyer at another Brussels law firm. I was at a seminar organised at the ALTIUS office.

The Belgian legislator has been busy over the summer. Although Belgium missed the 16 April 2026 deadline for transposing AIFMD II (Directive (EU) 2024/927), it completed the implementation with the Law of 22 July 2026. In addition to transposing AIFMD II, the Belgian legislator took the opportunity to introduce a number of welcome flexibilities to the Belgian UCITS and AIFM frameworks.

After a long wait, Belgium has adopted the act transposing the EU Directive on Empowering Consumers for the Green Transition (the “EmpCo Directive”) into national law. It prohibits certain practices related to environmental claims and expands information obligations towards consumers. The EmpCo Directive pursues two goals: (1) tackling unfair commercial practices that mislead consumers, such as greenwashing, and (2) enabling consumers to make more sustainable consumption choices.

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Our third and final part examines the ‘Bill containing various provisions on health‘ (the “Bill”), adopted without amendments by the federal Chamber of Representatives on 16 July 2026.

Le 1er février 2022 a vu entrer en vigueur une nouvelle législation venant modifier la loi du 2 août 2002 relative à la lutte contre les retards de paiement dans les transactions commerciales[1]. Cette loi institue des règles plus strictes tendant à lutter contre le retard de paiement dans les transactions commerciales, c’est-à-dire entre entreprises (B2B), en vue de protéger les entreprises contre les défaillances et les abus et maintenir leur trésorerie en bonne santé.

In February 2022, new legislation came into force amending the Act of 2 August 2002 on combating late payment in commercial transactions[1]. This Act introduces stricter rules designed to combat late payment in commercial transactions, i.e. between businesses (B2B), with a view to protecting businesses from insolvency and abuse and maintaining their cash flow in good health.

Op 1 februari 2022 is nieuwe wetgeving in werking getreden die de wet van 2 augustus 2002 betreffende de bestrijding van betalingsachterstanden bij handelstransacties wijzigt[1]. Deze wet voert strengere regels in ter bestrijding van betalingsachterstanden in handelstransacties, dat wil zeggen tussen ondernemingen (B2B), met als doel ondernemingen te beschermen tegen faillissementen en misbruik en hun kasmiddelen onder controle te houden.

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered.